← FDA Drug Approvals (Drugs@FDA)
EZETIMIBE AND SIMVASTATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2025-01-27
Drug application
- FDA Application #
ANDA209461- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EZETIMIBE AND SIMVASTATIN
- Generic name
- Ezetimibe
- Active ingredients
- EZETIMIBE; SIMVASTATIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TORRENT
- First approval
- 2025-01-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown